Presidential Advisory Committee on Gulf War Veterans' Illnesses
Final Report

REFERENCES

1. Abou-Donia, M.B., Wilmarth, K.R., Jensen, K.P., et al., "Neurotoxicity Resulting from Coexposure to Pyridostigmine Bromide, DEET, and Permethrin," Journal of Toxicology and Environmental Health 45:35-56, 1996.

2. Amato, A.A., McVey, A., Cha, C., et al., "Evaluation of Neuromuscular Symptoms in Veterans of the Persian Gulf War," Neurology, in press.

3. American Psychiatric Association, DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 4th edition (Washington, DC: American Psychiatric Association, 1994).

4. Ames, R.G., Steenland, K., Jenkins, B., et al., "Chronic Neurologic Sequelae to Cholinesterase Inhibition among Agricultural Pesticide Applicators," Archives of Environmental Health 50:440-444, 1995.

5. Baker, E.L., "Organic Solvent Neurotoxicity," Annual Review of Public Health 9:223-232, 1988.

6. Baker, M.S., and Strunk, H.K., "Medical Aspects of Persian Gulf Operations: Serious Infectious and Communicable Diseases of the Persian Gulf and Saudi Arabian Peninsula," Military Medicine 156:385-390, 1991.

7. Barrett, D.S., and Oehme, F.W., "A Review of Organophosphorus Ester-Induced Delayed Neurotoxicity," Veterinary and Human Toxicology 27:22-37, 1985.

8. Batres, A., Director, Readjustment Counseling Services, Department of Veterans Affairs, presentation to Presidential Advisory Committee on Gulf War Veterans' Illnesses staff, April 1996.

9. Beach, P., Blanck, R.R., Gerrity, T., et al., "Persian Gulf Veterans Coordinating Board: Organization, Mission, and Accomplishments," Federal Practitioner, December 1995.

10. Berg, S.W., "Post Persian Gulf Medical Findings in Military Reservists," presentation at the National Institutes of Health Technology Assessment Workshop on the Persian Gulf Experience and Health, April 1994.

11. Blanck, R.R., "Further Information about Persian Gulf War Health Questions," International Journal of Occupational Medicine, Immunology, and Toxicology 5:79-81, 1996.

12. Blanck, R.R., Chair, Clinical Working Group, Persian Gulf Veterans Coordinating Board, "Microsporidia in Persian Gulf Veterans' Stool Specimens," unpublished report to Presidential Advisory Committee on Gulf War Veterans' Illnesses, January 1996.

13. Blanck, R.R., USA Commander, Walter Reed Army Medical Center, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, May 1996.

14. Bohning, D.E., and Lippmann, M., "Particle Deposition and Pulmonary Defense Mechanisms," Environmental and Occupational Medicine, 2nd edition, W. Rom (ed.) (Boston, MA: Little, Brown and Co., 1992).

15. Brady, J., public comment before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, December 1995.

16. Brent, R.L., "Biological Factors Related to Male Mediated Reproductive and Developmental Toxicity," Male-Mediated Developmental Toxicity, A.F. Olshan and D.R. Mattison (eds.) (New York, NY: Plenum Press, 1994).

17. Brent, R.L., Head, Laboratory of Clinical and Environmental Teratology, Alfred I. DuPont Institute, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, June 1996.

18. Broudy, P., public comment before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, December 1995.

19. Buchwald, P., and Garrity, D., "Comparison of Patients with Chronic Fatigue Syndrome, Fibromyalgia, and Multiple Chemical Sensitivities," Archives of Internal Medicine 154:2049-2053, 1994.

20. Bukowski, G., and Lopez, D., Uranium Battlefields Home and Abroad: Depleted Uranium Use by the U.S. Department of Defense (Reno, NV: Citizen Alert and Rural Alliance for Military Accountability, 1993).

21. Bullman, T.A., and Kang, H.K., "Post-traumatic Stress Disorder and the Risk of Traumatic Deaths among Vietnam Veterans," Journal of Nervous and Mental Disease 182:604-610, 1994.

22. Burchfiel, J.L., and Duffy, F.H., "Organophosphate Neurotoxicity: Chronic Effects of Sarin on the Electroencephalogram of Monkey and Man," Neurobehavioral Toxicology and Teratology 4(6):767778, 1982.

23. Burke, T.A., Assistant Professor, Department of Health Policy and Management, Johns Hopkins University, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, September 1996.

24. Callahan, H.L., Portal, I.F., Bensinger, S.J., et al., "The Temperature Sensitivity of Leishmania Promastigotes In Vitro: A Model for Tropism In Vivo," Experimental Parasitology, in press.

25. Callahan, H.L., Portal, I.F., and Grögl, M., "Development of an In Vivo Leishmania Temperature Sensitivity Model: Preliminary Studies with Strains with Aberrant Tropism In Vivo," 44th Annual Meeting of the American Society of Tropical Medicine and Hygiene 53(2):215, 1995.

26. Campbell, P.A., Grishman, M.H., Harbert, T.L., et al., Persian Gulf War Family Support Program Progress Report, presented to the U.S. Congress by the Social Work Service, Department of Veterans Affairs, Washington, DC, July 1993.

27. Casa, K., "United States Used Radioactive Arms in the Gulf War," National Catholic Reporter, Aug. 25, 1995.

28. Chandra, A., and Mosher, W., "The Demography of Infertility and the Use of Medical Care for Infertility," Infertility and Reproductive Medicine Clinics of North America 5(2):283-296, 1994.

29. Chemical Carcinogens, 2nd edition, vol. 2: American Chemical Society Monograph 182, C.E. Searle (ed.) (American Chemical Society, Washington, DC: 1984).

30. Chess, C., "Improving Risk Communication in Government: Research Priorities," Risk Analysis 15(2)127-135, 1995.

31. Chrousos, G.P., and Gold, P.W., "The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis," Journal of the American Medical Association 267:1244-1252, 1992.

32. Clawson, R.E., U.S. Army Medical Materiel Development Activity, Fort Detrick, Frederick, briefing for Presidential Advisory Committee on Gulf War Veterans' Illnesses staff, December 1995.

33. Coate, B.D., Anderson, C.M., Gray, G.C., et al., "Comparative Study of Hospitalizations among Gulf War Veterans and Era Controls," abstract, 123rd Annual Meeting and Exhibition of the American Public Health Association, November 1995.

34. Coker, W., Consultant Specialist in Internal Medicine, British Ministry of Defence, "Overview of the Health of Coalition Forces," presentation at Department of Veterans Affairs National Conference: Current Concepts of Persian Gulf Veterans Illnesses, Long Beach, CA, August 1996.

35. Copeland, S.L., Central Intelligence Agency, Office of Weapons, Technology and Proliferation, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, April, May, and July 1996.

36. Cowan, D.N., DeFraites, R.F., Wishik, S.M., et al., "Preliminary Analysis of Birth Defects and Persian Gulf War Service," abstract, 123rd Annual Meeting and Exhibition of the American Public Health Association, November 1995.

37. Cowan, D.N., SRA Technologies, Inc., Falls Church, VA, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, June 1996.

38. Dan, B.B., Center for Bio-Medical Communication, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, September 1996.

39. Daxon, E.G., Department Chair, U.S. Army Armed Forces Radiobiology Research Institute, presentation at the National Institutes of Health Technology Assessment Workshop on the Persian Gulf Experience and Health, April 1994.

40. DeFraites, R.F., Preventive Medicine Staff Offices, Office of the Army Surgeon General, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, September 1996.

41. DeFraites, R.F., Wanat, E.R., Norwood, A.E., et al., Investigation of a Suspected Outbreak of an Unknown Disease among Veterans of Operation Desert Shield/Storm, 123d Army Reserve Command, Fort Benjamin Harrison, Indiana, April 1992 (Washington, DC: Walter Reed Army Institute of Research, 1992).

42. Depleted Uranium Citizens' Network, Radioactive Battlefields of the 1990s: The United States Army's Use of Depleted Uranium and its Consequences for Human Health and the Environment (Norway, ME: The Military Toxics Project, 1996).

43. Dietz, L.A., "Some Consequences of Using Depleted Uranium Metal," presentation at a public forum, Jonesborough, TN, November 1994.

44. Dietz, L.A., "Threat from Depleted Uranium Cannon Shells," Bulletin of Atomic Scientists, letters section, March 1991.

45. Dillon, D.C., Day, C.H., Whittle, J.A., et al., "Characterization of a Leishmania Tropica Antigen that Detects Immune Responses in Desert Storm Vicerotropic Leishmaniasis Patients," Proceedings of the National Academy of Sciences (USA) 92:7981-7982, 1995.

46. Dillon, D.C., Day, C.H., Whittle, J.A., et al., "The Molecular and Immunological Characterization of Leishmania Tropica Antigens: Serological and Cellular Responses by Viscerotropic Leishmaniasis Patients," VIII International Congress of Parasitology, 1994.

47. Dillon, D.C., Day, C.H., Whittle, J.A., et al., "The Molecular and Immunological Characterization of Leishmania Tropica Antigens: Serological and Cellular Responses by Viscerotropic Leishmaniasis Patients," 43rd Annual Meeting of the American Society of Tropical Medicine and Hygiene, 1994.

48. Doble, M.F., Fleishman-Hillard, Inc., testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, September 1996.

49. Doctor, B.P., Gentry, M.K., Bisko, N., et al., "Pyridostigmine Inhibition of Red Cell Acetylcholinesterase and Phenotyping of Butyrylcholinesterase: A Comparison in Gulf War Veterans and Normal Controls," abstract, 2nd Chemical and Biological Medical Treatment Symposium: An Exploration of Present Capabilities and Future Requirements for Chemical and Biological Medical Treatment, Spiez, Switzerland, July 1996.

50. Drake-Baumann, R., and Seil, F.J., "Effect of Long Term Anticholinesterase Exposure on Neuromuscular Function In Vitro," Society of Neuroscience Abstracts, in press.

51. Duelfer, C.A., Deputy Executive Director, United Nations Special Commission, briefing for the Presidential Advisory Committee on Gulf War Veterans' Illnesses, July 1996.

52. Dunn, M.A., U.S. Army Director, Clinical Consultation, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, April 1996.

53. Eitzen, E., U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, unpublished report to Presidential Advisory Committee on Gulf War Veterans' Illnesses, October 1995.

54. Engel, C.C., Engel, A.L., Campbell, S.J., et al., "Post-traumatic Stress Disorder Symptoms and Precombat Sexual and Physical Abuse in Desert Storm Veterans," Journal of Nervous and Mental Disease 181:683-688, 1993.

55. Etzel, R.A., and Ashley, D.L., "Volatile Organic Compounds in the Blood of Persons in Kuwait During the Oil Fires," International Archives of Occupational and Environmental Health 66:125-129, 1994.

56. Evenson, D., Professor, South Dakota State University and Olson Biochemistry Labs, correspondence to Presidential Advisory Committee on Gulf War Veterans' Illnesses, November 1996.

57. Fahey, D., public comment before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, November 1995.

58. Ford, J.S., former Combat Engineer, 307th Engineer Battalion, 82d Airborne Division, USA, public comment before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, October 1996.

59. Friedman, A., Kaufer, D., Shemer, J., et al., "Pyridostigmine Brain Penetration Under Stress Enhances Neutronal Excitability and Induces Early Immedicate Transcriptional Response," Nature Medicine 2(12):1383-1385, 1996.

60. Friedman, G.K., Texas Lung Institute, Houston, TX, presentation at the National Institutes of Health Technology Assessment Workshop on the Persian Gulf Experience and Health, April 1994.

61. Friedman, G.K., Texas Lung Institute, Houston, TX, personal communication to Presidential Advisory Committee on Gulf War Veterans' Illnesses, May 1996.

62. Friedman, M.J., Executive Director, National Center for Post-traumatic Stress Disorder, presentation to Presidential Advisory Committee on Gulf War Veterans' Illnesses staff, April 1996.

63. Fukuda, K., Straus, S., Hickie, I., et al., "The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study," Annals of Internal Medicine 121:953-959, 1994.

64. Gasser, R.A., Physician, Keesler Air Force Base, "Infectious Diseases in the CCEP," presentation at the Institute of Medicine, March 1995.

65. Gasser, R.A., Magill, A.J., Oster, C.N., et al., "The Threat of Infectious Disease in Americans Returning from Operation Desert Storm," New England Journal of Medicine 324(12):859-864, 1991.

66. Gebicke, M., Director, Military Operations and Capabilities Issues, U.S. General Accounting Office, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, May 1996.

67. Gentry, M.K., Bisko, N., Bartels, C.F., et al., "A Comparison of Blood Cholinesterases, In Vitro Pyridostigmine Inhibition, and Butyrylcholinesterase Phenotypes in Gulf War Veterans and Controls," abstract, 2nd Chemical and Biological Medical Treatment Symposium: An Exploration of Present Capabilities and Future Requirements for Chemical And Biological Medical Treatment, Spiez, Switzerland, July 1996.

68. Gentry, M.K., Powell, S.E., Doctor, B.P., et al., "In Vitro Pyridostigmine Inhibition of Red Cell Acetylcholinesterase: A Comparison in Gulf War Veterans and Normal Controls," abstract, 1996 Medical Defense Bioscience Review, Baltimore, MD, May 1996.

69. Gerr, F., and Letz, R., "Solvents," Environmental and Occupational Medicine, 2nd edition, W. Rom (ed.) (Boston, MA: Little, Brown and Co., 1992).

70. Glass, C.R., Arnkoff D.B., Wood, H., et al., "Cognition, Anxiety, and Performance on a Career-related Oral Examination," Journal of Counseling Psychology 42(1):47-54, 1995.

71. Glickson, M., Achiron, A., Ram, Z., et al., "The Influence of Pyridostigmine Administration on Human Neuromuscular Functions-Studies in Healthy Human Subjects," Fundamental and Applied Toxicology 16:288-298, 1991.

72. Gluckman, A.G., "A Statistical Study Correlating the Reported Cases of Gulf Syndrome to Battlefield Locations of Afflicted U.S. Army Personnel During the Iraq-Kuwait War, Part I, Method to Relate Troop Deployment and the Reported Cases of Gulf Syndrome and Probable Incidence of Maladies Defined by the International Code of Diseases ICD-9-CM," Report ARL-TR-800, U.S. Army Research Laboratory, Aberdeen Proving Ground, MD, July 1995.

73. Goldstein, G., Beers, S.R., Morrow, L.A., et al., "A Preliminary Neuropsychological Study of Persian Gulf Veterans," Journal of the International Neuropsychological Society 2(4):368-371, 1996.

74. Grass, G.J., Gunnery Sergeant, USMC, Camp Lejuene, NC, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, May 1996.

75. Gray, G.C., Coate, B.D., Anderson, C.M., et al., "The Postwar Hospitalization Experience of U.S. Veterans of the Persian Gulf War," New England Journal of Medicine 335:1505-1513, 1996.

76. Green, B.L., Professor of Psychiatry, Georgetown University, presentation to Presidential Advisory Committee on Gulf War Veterans' Illnesses staff, April 1996.

77. Gunderson, C.H., Lehmann, C.R., Sidell, F.R., et al., "Nerve Agents: A Review," Neurology 42:946-950, 1992.

78. Hales, B.F., and Robaire, B., "Paternally Mediated Effects on Development," Handbook of Developmental Toxicology (Boca Raton, FL: CRC Press, 1996).

79. Hebert, M., Potegal, M., Moore, T., et al., "Diazapam Exacerbates Conditioned Defeat in Hamsters (Mesocricetus auratus)," Pharmacology, Biochemistry & Behavior, in press.

80. Hebert, M., Potegal, M., and Meyerhoff, J., "Flight Elicited Attack and Priming of Aggression in 'Nonaggressive' Hamsters," Physiology and Behavior 56(4):671-675, 1994.

81. Heinzel, F.P., "Interleukin 12 and the Regulation of CD4+ T Cell Subset Responses during Murine Leishmaniasis," Parasitology Today 10:190-192, 1994.

82. Heinzel, F.P., Rerko, R.M., Ling, P., et al., "Interleukin 12 is Produced In Vivo During Endotoxemia and Stimulates Synthesis of Interferon-g," Infection and Immunity 62:4244-4249, 1994.

83. Heinzel, F.P., Schoenhaut D., Rerko R., et al., "Recombinant Murine IL-12 Cures Infection with Leishmania Major in Susceptible Mice," Journal of Experimental Medicine 177:1505-1509, 1993.

84. Heller, J.M., Senior Scientist, U.S. Army Center for Health Promotion and Preventive Medicine, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, August 1996.

85. Helmkamp, J.C., "United States Military Casualty Comparisons During the Persian Gulf War," Journal of Occupational Medicine 36(6):609-615, 1994.

86. Heron, E.A., Matthews, E.C., Lawson, T., et al., "MMPI-2 Profiles of Symptomatic Gulf Veterans," Journal of Clinical Psychology, in press.

87. Hickman, D., Lawrence Livermore National Laboratory, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, August 1996.

88. Honda, Y., Delzell, E., and Cole, P., An Updated Study of Mortality among Workers at a Petroleum Manufacturing Plant," Journal of Occupational and Environmental Medicine 37(2):194-200, 1995.

89. Husain, T., Kuwaiti Oil Fires: Regional Environmental Perspectives (Oxford, UK: Pergamon Press, 1995).

90. Hyams, K.C., Hanson, K., Wignall, F.S., et al., "The Impact of Infectious Diseases on the Health of U.S. Troops Deployed to the Persian Gulf During Desert Shield and Desert Storm," Clinical Infectious Diseases 20:1497-1504, 1995.

91. Hyams, K.C., Wignall, F.S., and Roswell, R., "War Syndromes and Their Evaluation: From the U.S. Civil War to the Persian Gulf War," Annals of Internal Medicine 125(5):398-405, 1996.

92. Hyman, E.S., Physician, New Orleans, LA, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, February 1996.

93. Hyman, E.S., Physician, New Orleans, LA, "Proposal for Desert Storm Syndrome Study: Grant Application to Department of Defense," May 31, 1995.

94. Hyman, E.S., "A Urinary Marker for Occult Systemic Coccal Disease," Nephron 68:314-326, 1994.

95. Institute of Medicine, Evaluation of the Department of Defense Persian Gulf Comprehensive Clinical Evaluation Program (Washington, DC: National Academy Press, 1996).

96. Institute of Medicine, Health Consequences of Service During the Persian Gulf War: Initial Findings and Recommendations for Immediate Action (Washington, DC: National Academy Press, 1995).

97. Institute of Medicine, Health Consequences of Service During the Persian Gulf War: Recommendations for Research and Information Systems (Washington, DC: National Academy Press, 1996).

98. Institute of Medicine, Veterans at Risk: The Health Effects of Mustard Gas and Lewisite (Washington, DC: National Academy Press, 1993).

99. Jamal, G.A., Hansen, S., Apartopoulos, F., et al., "The Gulf War Syndrome: Is There Evidence of a Dysfunction in the Nervous System?," Journal of Neurology, Neurosurgery, and Psychiatry 60:449-451, 1996.

100. Johnson, D., Associate Professor, Department of Occupational and Environmental Health, University of Oklahoma, presentation at the National Institutes of Health Technology Assessment Workshop on the Persian Gulf Experience and Health, April 1994.

101. Johnson, D., Associate Professor, Department of Occupational and Environmental Health, University of Oklahoma, personal communication to Presidential Advisory Committee on Gulf War Veterans' Illnesses, June 1996.

102. Johnson-Winegar, A., Director, Medical, Chemical, and Biological Defense Research, U.S. Army Medical Research Development Command, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, May 1996.

103. Johnson-Winegar, A., Director, Medical, Chemical, and Biological Defense Research, U.S. Army Medical Research Development Command, Fort Detrick, briefing for Presidential Advisory Committee on Gulf War Veterans' Illnesses staff, December 1995.

104. Joseph, S.C., Assistant Secretary (Health Affairs), Department of Defense, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, September 1996.

105. Kadivar, H., and Adams, S.C., "Treatment of Chemical and Biological Warfare Injuries: Insights Derived from the 1984 Iraqi Attack on Majoon Island," Military Medicine 156:171-172, 1991.

106. Kaiser K.S., Hawksworth A.W., Gray G.C., et al., "A Comparison of Self-reported Symptoms among Active Duty Seabees: Gulf War Veterans Versus Era Controls," abstract, 123rd Annual Meeting and Exhibition of the American Public Health Association, November 1995.

107. Kang, H.K., Environmental Epidemiology Service, Department of Veterans Affairs, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, November 1995.

108. Kang, H.K., and Bullman, T.A., "Mortality among U.S. Veterans of the Persian Gulf War," New England Journal of Medicine 335:1498-1504, 1996.

109. Kang, H.K., Dalager, N.A., and Lee, K.Y., "Health Surveillance of Persian Gulf War Veterans-A Review of the DVA Persian Gulf Registry Data," unpublished report, Department of Veterans Affairs, March 1996.

110. Keeler, J.R., Hurst, C.G., and Dunn, M.A., "Pyridostigmine Used as a Nerve Agent Pretreatment Under Wartime Conditions," Journal of the American Medical Association 266(5):693-695, 1991.

111. Kelly, D.J., Chan, C.T., Paxton, H., et al., "Comparative Evaluation of a Commercial Enzyme Immunoassay for the Detection of Human Antibody to Rickettsia Typhi," Clinical and Diagnostic Laboratory Immunology 2(3):356-360, 1995.

112. Keogh, J., Medical Director and Principal Investigator, Follow-up Program of Gulf War Veterans Wounded by Depleted Uranium Munitions, University of Maryland School of Medicine; Hooper, F., DU Program Epidemiologist, University of Maryland School of Medicine; Kane, R., Psychology Service, Baltimore VA Medical Center; et al., briefing for Presidential Advisory Committee on Gulf War Veterans' Illnesses staff, June 1996.

113. Kessler, R.C., McGonagle, K., Zhao, S., et al., "Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States," Archives of General Psychiatry 51:8-19, 1994.

114. Kessler, R.C., Sonnega, A., Bromet, E., et al., "Post-traumatic Stress Disorder in the National Comorbidity Survey," Archives of General Psychiatry 52:1048-1060, 1995.

115. Kinty, S., Administrative Staff, Deployment Surveillance Team, Department of Defense, personal communication to Presidential Advisory Committee on Gulf War Veterans' Illnesses, June 1996.

116. Kisby, G.E., Sweatt, C., and Spencer, P.S., "Role of DNA Repair in Protecting Mature Nervous Tissue from DNA Damage," abstract, Journal of Cellular Biochemistry 21A:348, 1995.

117. Klaassen, C.D., Casarett and Doull's Toxicology: The Basic Science of Poisons, 5th edition, M.O. Amdur and J. Doull (eds.) (New York, NY: McGraw-Hill, 1996).

118. Klenke, W.A., U.S. Army Office of the Surgeon General, NBC Defense Staff Official, correspondence to the Presidential Advisory Committee on Gulf War Veterans' Illnesses, "Drug and Vaccine Usage During Operation Desert Shield/Storm," December 1991.

119. Koenigsberg, E.J., Director, Persian Gulf Veterans' Illnesses Investigation Team, Department of Defense, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, October 1995, April, May, July, and August 1996.

120. Kotler-Cope, S., Milby, J.B., Roswell, R., et al., "Neuropsychological Deficits in Persian Gulf War Veterans: A Preliminary Report," abstract, Annual Meeting of the International Neuropsychological Society, February 1996.

121. Kovera C.A., Anger, K, Campbell, K.A., et al., "Computer-administration of Questionnaires: A Health Screening System (HSS) Developed for Veterans," Neurotoxicology and Teratology, in press.

122. Krengel, M., White, R.F., Diamond, R., et al., "A Comparison of NES2 and Traditional Neuropsychological Tests in a Neurologic Patient Sample," Neurotoxicology and Teratology 18:435-439, 1996.

123. Krivda, S.J., Roy, M.J., Chung, R.C., et al., "Cutaneous Findings in Gulf War Veterans," Archives of Dermatology 132:846-847, 1996.

124. Kroenke, K., and Price, R., "Symptoms in the Community-Prevalence, Classification, and Psychiatric Comorbidity," Archives of Internal Medicine 153:2474-2480, 1993.

125. Kumar, P., Gupta, B.N., Pandya, K.P., et al., "Behavioral Studies in Petroleum Pump Workers," International Archives of Occupational Environmental Health 61:35-38, 1988.

126. Labbate, L.A., and Snow, M.P., "Post-traumatic Stress Symptoms among Soldiers Exposed to Combat in the Persian Gulf," Hospital and Community Psychiatry 43:831-833, 1992.

127. Langford, M.J., U.S. Army Medical Materiel Development Activity, Fort Detrick, briefing for Presidential Advisory Committee on Gulf War Veterans' Illnesses staff, December 1995.

128. Lasseter, K.C., and Garg, D.C., "A Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of Pyridostigmine When Given in Single and Multiple Doses to Males and Females in Different Weight Groups," clinical/pharmacokinetics report prepared for USAMMDA, by Clinical Research Services and South Florida Drug Research Corp., 1996.

129. Layton, D.W., and Armstrong, A., "Methodological Consideration for Determining Cleanup Limits for Uranium in Treated and Untreated Soils," Journal of Soil Contamination 3(4):319-348, 1994.

130. Leach, L.J., Maynard, E.A., Hodge, C.H., et al., "A Five Year Inhalation Study with Natural Uranium Dioxide Dust, I. Retention and Biological Effect in the Monkey, Dog, and Rat," Health Physics 18:599-612, 1970.

131. Leach, L.J., Yuile, C.L., Hodge, C.H., et al., "A Five Year Inhalation Study with Natural Uranium Dioxide Dust, II. Postexposure Retention and Biologic Effects in the Monkey, Dog, and Rat," Health Physics 25:239-258, 1973.

132. Lee, P.R., Assistant Secretary for Health, Department of Health and Human Services, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, September 1996.

133. Leggett, R.W., "The Behavior and Chemical Toxicity of U in the Kidney: A Reassessment," Health Physics 57(3):365-383, 1989.

134. LeMasters, G., Department of Occupational and Environmental Health, University of Cincinnati School of Medicine, presentation to Presidential Advisory Committee on Gulf War Veterans' Illnesses staff, May 1996.

135. Lepera, M., Associate Director for Fuels and Lubricants, U.S. Army Mobility Technology Center-Belvoir, correspondence to Presidential Advisory Committee on Gulf War Veterans' Illnesses, August 1996.

136. Lewis, G.E. Jr., Commander, Medical Materiel Development Activity, U.S. Army Medical Research and Materiel Command, correspondence to Presidential Advisory Committee on Gulf War Veterans' Illnesses, May 1996.

137. Linet, M., Stewart, W., Celentano, D., et al., "An Epidemiological Study of Headache among Adolescents and Young Adults," Journal of American Medical Association 261:2211-2216, 1989.

138. Lo, S.-C., Chief, Division of Molecular Pathobiology, Armed Forces Institute of Pathology, Walter Reed Army Institute of Research, personal communication to Presidential Advisory Committee on Gulf War Veterans' Illnesses, July 1996.

139. Loewenstein-Lichtenstein, Y., Schwarz, M., Glick, D., et al., "Genetic Predisposition to Adverse Consequences of Anti-Cholinesterases in 'Atypical' BCHE Carriers," Nature Medicine 1(10):1082-1085, 1995.

140. Lohs, K., Delayed Toxic Effects of Chemical Warfare Agents-Stockholm International Peace Research Institute (SIPRI) (Stockholm and New York: Almqvist and Wiksell International, 1975).

141. Lopez, D., Friendly Fire: The Link Between Depleted Uranium Munitions and Human Health Risks (Norway, ME: The Military Toxics Project, 1995).

142. Lymburner, D., public comment before the Presidential Advisory Committee on Gulf War Veterans Illnesses, March 1996.

143. Lynberg, M.C., and Edmonds, L.D., "Surveillance of Birth Defects," Public Health Surveillance, W. Halperin and E. Baker (eds.) (New York, NY: Van Nostrand Reinhold, 1992).

144. Lyons, P.D., Staff Sergeant, USA, public comment before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, February 1996.

145. Magill, A.J., Infectious Disease Specialist, Walter Reed Army Institute of Research, "Leishmaniasis in Persian Gulf Veterans," briefings for Presidential Advisory Committee on Gulf War Veterans' Illnesses staff, December 1995, May 1996.

146. Magill, A.J., Grögl, M., Gasser, R.A., et al., "Visceral Infection Caused by Leishmania Tropica in Veterans of Operation Desert Storm," New England Journal of Medicine 328(19):1383-1387, 1993.

147. Martin, B., former Sergeant, 37th Engineering Brigade, USA, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, July 1996.

148. Martin, J.E., Deputy Director, Persian Gulf Veterans' Illnesses Investigation Team, Department of Defense, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, April, May, and July 1996.

149. Mather, S.H., Director, Office of Public Health and Environmental Hazards, Department of Veterans Affairs, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, May 1996.

150. McCain, W.C., U.S. Army Center for Health Promotion and Preventive Medicine, "Toxicological Study 75-48-2665, Acute Oral Toxicity Study of Pyridostigmine Bromide, Permethrin, and DEET in the Laboratory Rat," briefing for Presidential Advisory Committee on Gulf War Veterans' Illnesses staff, March 1996.

151. McCain, W.C., Lee, R., Johnson, M.S., et al., "Acute Oral Toxicity Study of Pyridostigmine Bromide, Permethrin, and DEET in the Laboratory Rat," Journal of Toxicology and Environmental Health 50:101-112, in press.

152. McCarroll, J.E., Ursano, R.J., and Fullerton, C.S., "Symptoms of Post-traumatic Stress Disorder Following Recovery of War Dead," American Journal of Psychiatry 150(12):1875-1877, 1993.

153. McCarroll, J.E., Ursano, R.J., and Fullerton, C.S., "Symptoms of PTSD Following Recovery of War Dead: 13-15 Month Follow-Up," American Journal of Psychiatry 152(6):939-941, 1995.

154. McDiarmid, M.A., Jacobson-Kram, D., Kolodner, K., et al., "Increased Frequencies of Sister Chromatid Exchange in Soldiers Deployed to Kuwait," Mutagenesis 10(3):263-265, 1995.

155. McEwen, B.S., and Schmeck, H.M., The Hostage Brain (New York, NY: Rockefeller University Press, 1994).

156. McGuire, S.A., "Chemical Toxicity of Uranium Hexafluoride Compared to Acute Effects of Radiation, Final Report, NUREG 1391" (Washington, DC: U.S. Nuclear Regulatory Commission, 1991).

157. McLaughlin, J.K., "Renal Cell Cancer and Exposure to Gasoline: A Review," Environmental Health Perspectives Supplements 101(Suppl. 6):111-114, 1993.

158. McNally, R., Assistant Vice-President, Science Applications International Corp., testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, April, May, and July 1996.

159. McNamara, B.P., and Leitnaker, F., Toxicological Basis for Controlling Emission of GB into the Environment-Edgewood Arsenal Special Publication EASP 100-98 (Aberdeen Proving Ground, MD: U.S. Army Edgewood Arsenal, 1971).

160. Miller, C., Department of Family Practice, University of Texas Health Science Center at San Antonio, TX, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, February 1996.

161. Mills, C., public comment before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, June 1996.

162. Mitrokhin, I.A., Political Affairs Officer, United Nations Special Commission, briefing for the Presidential Advisory Committee on Gulf War Veterans' Illnesses, July 1996.

163. Moldenhauer, E.T., Persian Gulf Veterans' Illnesses Investigation Team, Department of Defense, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, August 1996.

164. Mullick, F., Director, Center for Advanced Pathology, Armed Forces Institute of Pathology, correspondence to Presidential Advisory Committee on Gulf War Veterans' Illnesses, September 1996.

165. Mumford, J.L., Lewtas, J., Williams, K., et al., "Mutagenicity of Organic Emissions from Unvented Kerosene Heaters in a Chamber Study," Journal of Toxicology and Environmental Health 36:151-159, 1992.

166. Murphy, D.L., Campbell, P.A., Rodell, D.E., et al., Persian Gulf War Family Support Program Final Report, presented to the U.S. Congress by the Department of Veterans Affairs, June 1994.

167. Myasthenia Gravis Foundation of America (Chicago, IL), Physicians Manual, Myasthenia Gravis, undated.

168. Myers, R.C., Director, Michigan Biologic Products Institute, Lansing, MI, "Mycoplasma in Anthrax Vaccine," correspondence to A. Johnson-Winegar, U.S. Army Medical Research and Materiel Command, Fort Detrick, May 1996.

169. Nalls, A.L., Jr., Persian Gulf Veterans' Illnesses Investigation Team, Department of Defense, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, May 1996.

170. Natelson, B.H., Ottenweller, J.E., Goldstein, C., et al., "Persisting Effects of Oral Pyridostigmine Bromide on the Behavior of Rats," abstract, Annual Meeting of the Society of Neuroscience, November 1996.

171. National Research Council, Health Effects of Permethrin-Impregnated Army Battle-Dress Uniforms (Washington, DC: National Academy Press, 1994).

172. National Research Council, Health Risks of Radon and Other Internally Deposited Alpha-emitters (BEIR IV) (Washington, DC: National Academy Press, 1988).

173. National Research Council, Improving Risk Communication (Washington, DC: National Academy Press, 1989).

174. National Research Council, Possible Long-Term Health Effects of Short-Term Exposure to Chemical Agents-vol. 1, Anticholinesterase and Anticholinergics (Washington, DC: National Academy Press, 1982).

175. National Research Council, Possible Long-Term Health Effects of Short-Term Exposure to Chemical Agents-vol. 3, Final Report on 'Current Health Status of Test Subjects,' (Washington, DC: National Academy Press, 1985).

176. National Research Council, Risk Assessment in the Federal Government: Managing the Process (Washington, DC: National Academy Press, 1983).

177. National Research Council, Understanding Risk: Informing Decisions in a Democratic Society (Washington, DC: National Academy Press, 1996).

178. National Veterans Legal Services Program, The Self Help Guide for Veterans of the Gulf War (Washington, DC: 1995).

179. Nelson, K., and Holmes, L.B., "Malformations Due to Presumed Spontaneous Mutations in Newborn Infants," New England Journal of Medicine 320:19-23, 1989.

180. Nelson, R.A., "Determining Types of Health Effects to Persian Gulf Veterans Due to Exposure to Occupational Hazards," Thesis No. AFIT/GEE/ENV/95D-13, Air University, USAF Institute of Technology, Wright-Patterson Air Force Base, OH, 1995.

181. Newmark, J., and Clayton, W.L., "Persian Gulf Illnesses: Preliminary Neurological Impressions," Military Medicine 160:505-507, 1995.

182. Nicolson, G.L., testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, February 1996.

183. Nicolson, G.L., and Nicolson, N.L., "Diagnosis and Treatment of Mycoplasma Infections," correspondence of June 20, 1995 forwarded to Presidential Advisory Committee on Gulf War Veterans' Illnesses, August 1995.

184. Norris, F.H., Associate Professor, Department of Psychology, Georgia State University, presentation to Presidential Advisory Committee on Gulf War Veterans' Illnesses staff, April 1996.

185. O'Donnell, F.L., Physician, Office of the Army Surgeon General, "Preventive Medicine Measures," presentation at Department of Veterans Affairs National Conference: Update on Health Consequences of Persian Gulf Service, Baltimore, MD, July 1995.

186. Olah, L., public comment before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, July 1996.

187. Oldfield, E.C., Wallace, M.R., Hyams, K.C., et al., "Endemic Infectious Diseases of the Middle East," Reviews of Infectious Diseases 13(Suppl. 3):S199-S217, 1991.

188. Oleshansky, M.A., and Meyerhoff, J.L., "Acute Catecholaminergic Responses to Mental and Physical Stressors in Man," Stress Medicine 8:175-179, 1992.

189. Olney, R.S., Birth Defects and Genetic Diseases Branch, Centers for Disease Control and Prevention, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, June 1996.

190. Osimitz, T.G., and Grothaus, R.H., "The Present Safety Assessment of DEET," Journal of American Mosquito Control Association 11:274-278, 1995.

191. Overstreet, C., The Military Toxics Project, personal communication to Presidential Advisory Committee on Gulf War Veterans' Illnesses, October 1995.

192. Patrick, J., Professor, Baylor College of Medicine, "Neurobiology/Genetics of Nerve Agents," briefing for the Department of Veterans Affairs Persian Gulf Scientific Expert Committee, December 1995.

193. Patrick, J., Professor, Baylor College of Medicine, personnal communication to Presidential Advisory Committee on Gulf War Veterans' Illnesses, April 1996.

194. Paul, M., and Himmelstein, J., "Reproductive Hazards in the Workplace: What the Practitioner Needs to Know about Chemical Exposures," Obstetrics and Gynecology 71(6/1):921-938, 1988.

195. Penman, A.D., and Tarver, R.S., "No Evidence of Increase in Birth Defects and Health Problems among Children Born to Persian Gulf War Veterans in Mississippi," Military Medicine 161:1-6, 1996.

196. Penn, A.S., Deputy Director, National Institute of Neurological Diseases and Stroke, personal communication to Presidential Advisory Committee on Gulf War Veterans' Illnesses, September 1996.

197. Perconte, S., Wilson, A., Pontius, E., et al., "Psychological and War Stress Symptoms among Deployed and Non-Deployed Reservists Following the Persian Gulf War," Military Medicine 158:516-521, 1993.

198. Perconte, S., Wilson, A., Pontius, E., et al., "Unit-Based Intervention for Gulf War Soldiers Surviving a SCUD Missile Attack: Program Description and Preliminary Findings," Journal of Traumatic Stress 6(2):225-238, 1993.

199. Pierce, P.F., "Physical and Emotional Health of Gulf War Veteran Women," Aviation, Space, and Environmental Medicine, in press.

200. Pierce, P.F., Assistant Professor, University of Michigan, public comment before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, July 1996.

201. Pierce, P.F., Assistant Professor, University of Michigan, testimony at hearing of U.S. House of Representatives, Committee on Government Reform and Oversight, Subcommittee on Human Resources and Intergovernmental Relations, March 1996.

202. Pittman, P.R., "Anthrax and Botulinum Vaccines: Antibody Prevalence and Immune Response to a Booster Dose in Military Personnel Initially Vaccinated During Desert Shield/Desert Storm: Preliminary Report," in review for submission to U.S Food and Drug Administration to supplement BB-IND3723, March 1995.

203. Pleas, W., public comment before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, June 1996.

204. Pontius, E.B., Wilson, A.T., Sharp, P.H., et al., "DOD-VA War Stress Collaborative Study: Project Summary," The General Well-Being of Gulf War Era Service Personnel from the States of Pennsylvania and Hawaii: A Survey (Washington, DC: Walter Reed Army Institute of Research, 1994).

205. Porter, H.O., "Aviators Intoxicated by Inhalation of JP-5 Fuel Vapors," Aviation, Space, and Environmental Medicine 61(7):654-656, 1990.

206. Potegal, M., "Aggression and Aggressiveness in Female Golden Hamsters," Of Mice and Woman, B. Jorkqvist and P. Niemela (eds.) (San Diego, CA: Academic Press, 1992).

207. Potegal, M., Ferris, C., Hebert, M., et al., "Attack Priming in Female Syrian Golden Hamsters is Mediated by a C-Fos Coupled Process within the Corticomedial Amygdala," Neuroscience, in press.

208. Potegal, M., Hebert, M., de Coster, M., et al., "Brief, High Frequency Stimulation of the Corticomedial Amygdala Induces a Delayed and Prolonged Increase of Aggressiveness in Male Syrian Golden Hamsters," Behavioral Neuroscience 110(2):1-12, 1996.

209. Potegal, M., Huhman, K.L., Moore, T.O., et al., "Conditioned Defeat in the Syrian Golden Hamster (Mesocticetus auraw)," Behavioral and Neural Biology 60(2):93-102, 1993.

210. Proctor, S., Wolfe, J., and Freidman, M., "Evaluation of Health Symptoms Reported by Gulf War Veterans," presentation at the Annual Meeting of the International Society for Environmental Epidemiology, September 1994.

211. Reeves, W., Chief, Division of Viral Exanthems and Herpes Virus Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, November 1995.

212. Reeves, W., Chief, Division of Viral Exanthems and Herpes Virus Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, presentation to Presidential Advisory Committee on Gulf War Veterans' Illnesses staff, September 1996.

213. Resta, J., Program Manager, Deployment Environmental Exposure Surveillance Program, U.S. Army Center for Health Promotion and Preventive Medicine, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, September 1996.

214. Revell, T., "The Gulf War Syndrome," British Medical Journal 310:1073, 1995.

215. Ross, M.C., and Wonders, J., "An Exploration of the Characteristics of Post-traumatic Stress Disorder in Reserve Forces Deployed During Desert Storm," Archives of Psychiatric Nursing 7:265-269, 1993.

216. Roswell, R.H., Executive Director, Persian Gulf Veterans Coordinating Board, correspondence to Presidential Advisory Committee on Gulf War Veterans' Illnesses, October 1996.

217. Roswell, R.H., Executive Director, Persian Gulf Veterans Coordinating Board, written testimony submitted to the Presidential Advisory Committee on Gulf War Veterans' Illnesses, September 1996.

218. Russell, J.J., Kathren, R.L., and Dietert, S.E., "A Histological Kidney Study of Uranium and Non-Uranium Workers," Health Physics 70(4):466-472, 1996.

219. Russell, P.K., Department of International Health, Johns Hopkins University, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, April 1996.

220. Sander, D.L., letter to Anna El-Quidad, transcriptory statement of Medical Board of the Myasthenia Gravis Foundation of America (Durham, NC), January 1995.

221. Savage, E.P., Keefe, T.J., Mounce, L.M., et al., "Chronic Neurologic Sequelae of Acute Organophosphate Pesticide Poisoning," Archives of Environmental Health 43:38-45, 1988.

222. Schappert, S.M., "National Ambulatory Medical Care Survey: 1989 Summary," Vital Health Statistics 13:1-80, 1992.

223. Schulte, P.A., Director, Education and Information Division, National Institute for Occupational Safety and Health, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, September 1996.

224. Schwarz, M., Glick, D., Loewenstein, Y., et al., "Engineering of Human Cholinesterases Explains and Predicts Diverse Consequences of Administration of Various Drugs and Poisons," Pharmacology and Therapy 67(2):283-322, 1995.

225. Scialli, A.R., Lione, A., Boyle Padgett, G.K., et al., editors, Reproductive Effects of Chemical, Physical, and Biologic Agents (Baltimore, MD: The Johns Hopkins University Press, 1995).

226. Scotnicki, J., public comment before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, March 1996.

227. Scott, K.C., Head of Medical Services, Canadian Forces, presentation at Department of Veterans Affairs National Conference: Current Concepts of Persian Gulf Veterans Illnesses, Long Beach, CA, August 1996.

228. Sharabi, Y., Danon, Y.L., Berkenstadt, H., et al., "Survey of Symptoms Following Intake of Pyridostigmine During the Persian Gulf War," Israeli Journal of Medical Sciences 27:656-658, 1991.

229. Shelton, S.P., Professor, University of New Mexico, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, August 1996.

230. Slatkin, N., Executive Director, Central Intelligence Agency, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, November 1996.

231. Sloan, P., Arsenault, L., Hilsenroth, M., et al., "Assessment of Noncombat, War-Related Post-traumatic Stress Symptomatology: Validity of the PK, PS, and IES Scales," Psychological Assessment 3:37-41, 1996.

232. Sloan, P., Arsenault, L., Hilsenroth, M., et al., "Rorschach Measures of Post-traumatic Stress in Persian Gulf War Veterans," Journal of Personality Assessment 64(3):397-414, 1995.

233. Sloan, P., Arsenault, L., Hilsenroth, M., et al., "Rorschach Measures of Post-traumatic Stress in Persian Gulf War Veterans: A Three-Year Follow-Up Study," Journal of Personality Assessment 66(1):54-64, 1996.

234. Sloan, P., Arsenault, L., Hilsenroth, M., et al., "Use of the Mississippi Scale for Combat-Related PTSD in Detecting War-related, Non-combat Stress Symptomology," Journal of Clinical Psychology 51(6):799-801, 1995.

235. Sloan, P., Arsenault, L., McCormick, W.A., et al., "Early Intervention with Appalachian Marine Reservists in Operation Desert Storm," National Center for Post-traumatic Stress Disorder Clinical Newsletter, Winter 1993.

236. Sloan, P., Arsenault, L., McCormick, W.A., et al., "Initial Contact Interviews with Marine Reservists in Operation Desert Storm," Returning Persian Gulf Troops: First Year Findings (West Haven, CT: Department of Veterans Affairs Northeast Program Evaluation Center, 1992).

237. Sohler, P., Smith, L., Welk, R., et al., "Psychological Adjustment in ODS/S Veterans," Returning Persian Gulf Troops: First Year Findings (West Haven, CT: Department of Veterans Affairs Northeast Program Evaluation Center, 1992).

238. Sostek, M.B., "High Prevalence of Chronic Gastrointestinal Symptoms in a National Guard Unit of Persian Gulf Veterans," American Journal of Gastroenterology, in press.

239. Southwick, S., Morgan, A., Nagy, L., et al., "Trauma-Related Symptoms in Veterans of Operation Desert Storm: A Preliminary Report," American Journal of Psychiatry 150(10):1524-1528, 1993.

240. Southwick, S., Morgan, C.A., Darnell, A., et al., "Trauma-Related Symptoms in Veterans of Operation Desert Storm: A 2-Year Follow-Up," American Journal of Psychiatry 152:1150-1155, 1995.

241. Steenland, K., Jenkins, B., Ames, R.G., et al., "Chronic Neurological Sequelae to Organophosphate Pesticide Poisoning," American Journal of Public Health 84:731-736, 1994.

242. Stevens, R., Pinto, J., Mamane, Y., et al., "Chemical and Physical Properties of Emissions from Kuwaiti Oil Fires," Water Science Technology 27(7-8):223-233, 1993.

243. Stitler, J.M., Ballou, W.R., Eckels, K.H., et al., "Good Manufacturing Practices (GMP) Production of Leishmania Skin Test Antigen: Production of a Microfluidized Lysate," 44th Annual Meeting of American Society of Tropical Medicine and Hygiene, 1995.

244. Stitler, J.M., Ballou, W.R., Eckels, K.H., et al., "Good Manufacturing Practices (GMP) Production of Leishmania Skin Test Antigen: Protocol Requirements for Investigational New Drug (IND) Application," 43rd Annual Meeting of American Society of Tropical Medicine and Hygiene, 1994.

245. Stretch, R.H., Bliese, P.D., Marlowe, D.H., et al., "Physical Health Symptomatology of Gulf War-era Service Personnel from the States of Pennsylvania and Hawaii," Military Medicine 160:131-136, 1995.

246. Stretch, R.H., Bliese, P.D., Marlowe, D.H., et al., "Psychological Health of Gulf War-era Military Personnel," Military Medicine 161:257-261, 1996a.

247. Stretch, R.H., Marlowe, D.H., Wright, K.M., et al., "Post-traumatic Stress Disorder Symptoms among Gulf War Veterans," Military Medicine 161:407-410, 1996b.

248. Stucker, J.P., Schank, J.F., Dombey-Moore, B., Assessment of DOD Fuel Standardization Policies, Report MR-396-OSD (Santa Monica, CA: Rand National Defense Research Inst., 1994).

249. Sullivan, P., Senior Vice President, Gulf War Veterans of Georgia, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, April 1996.

250. Sutker, P.B., Davis, J.M., Uddo, M., et al., "Assessment of Psychological Distress in Persian Gulf Troops: Ethnicity and Gender Comparisons," Journal of Personality Assessment 64(3):415-427, 1995.

251. Sutker, P.B., Uddo, M., Brailey, K., et al., "Operation Desert Shield/Storm (ODS) Returnee Evaluation, Debriefing, and Treatment Program Report, Returning Persian Gulf Troops: First Year Findings (West Haven, CT: Department of Veterans Affairs Northeast Program Evaluation Center, 1992).

252. Sutker, P.B., Uddo, M., Brailey, K., et al., "Psychological Symptoms and Psychiatric Diagnoses in Operation Desert Storm Troops Serving Graves Registration Duty," Journal of Traumatic Stress 7(2):159-171, 1994.

253. Sutker, P.B., Uddo, M., Brailey, K., et al., "Psychopathology in War-zone Deployed and Nondeployed Operation Desert Storm Troops Assigned Graves Registration Duties," Journal of Abnormal Psychology 103(2):383-390, 1994.

254. Sutker, P.B., Uddo, M., Brailey, K., et al., "War-zone Trauma and Stress-related Symptoms in Operation Desert Shield/Storm (ODS) Returnees," Journal of Social Issues 49(4):33-50, 1993.

255. Sutker, P.B., Uddo, M., Davis, J.M., et al., "War Zone Stress, Personal Resources, and PTSD in Persian Gulf War Returnees," Journal of Abnormal Psychology 104:444-452, 1995.

256. Tabler, D., Deputy Assistant Secretary, Health Services Financing, Department of Defense, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, June 1996.

257. Thomas, T.L., Kang, H.K., and Dalager, N.A., "Mortality among Women Vietnam Veterans, 1973-1987," American Journal of Epidemiology 134:973-980, 1991.

258. Tinker, T., Health Education Specialist, Division of Health Education, Agency for Toxic Substances and Disease Registry, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, September 1996.

259. Toohey, R., Director, Radiation Internal Dose Information Center, Environmental and Health Sciences Division, Oak Ridge Associated Universities, personal communication to Presidential Advisory Committee on Gulf War Veterans' Illnesses, June 1996.

260. Triplett, B., "Depleted Uranium: One Man's Weapon, Another Man's Poison," Vietnam Veterans of America Veteran, March 1996.

261. Tuite, J.J., III, Director, Gulf War Resource Foundation, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, April 1996.

262. United Nations Special Commission (UNSCOM) Reports to the Security Council, S/23268 (Dec. 4, 1991); S/24108 (June 16, 1992); S/1995/864 (Oct. 11, 1995); S/1995/ (Dec. 17, 1995).

263. U.S. Army, Center for Health Promotion and Preventive Medicine Report, "Acute Oral Toxicity Study of Pyridostigmine Bromide, Permethrin, and DEET in the Laboratory Rat-Toxicology Study," fact sheet 75-48-2665, 1995.

264. U.S. Army, Chemical Research, Development and Engineering Center, Material Safety Data Sheet, Lethal Nerve Agent, GD and Thickened GD, Poison Gas, FM 3-9, December 1990.

265. U.S. Army, Environmental Hygiene Agency, Final Report: Kuwait Oil Fire Health Risk Assessment, 5 May - 3 December 1991, Report No. 39-26-L192-91, February 1994.

266. U.S. Army, Environmental Hygiene Agency, Kuwait Oil Fire Health Risk Assessment Project, Industrial Hygiene Portion, unpublished field notes and data log from May 1991 provided to Presidential Advisory Committee on Gulf War Veterans' Illnesses, May 1996.

267. U.S. Army, Environmental Policy Institute, Health and Environmental Consequences of Depleted Uranium Use in the U.S. Army: Technical Report," June 1995.

268. U.S. Army, Medical Research Institute of Infectious Diseases, Protocol: (Retrospective) Assessment of the Health of Workers Formerly Employed at Fort Detrick, MD, P.R. Pittman, Principal Investigator, September 1996.

269. U.S. Army, Medical Research Institute of Chemical Defense, Technical Memorandum 90-4: Clinical Notes on Chemical Casualty Care (Aberdeen Proving Grounds, MD: U.S. Army, Medical Research Institute of Chemical Defense, 1990).

270. U.S. Army, Office of the Surgeon General, "Pretreatment of Organophosphate Poisoning in the Management of Nerve Gas Exposure-Amendment #29 to IND 23,509," May 1992.

271. U.S. Army, Research Institute of Environmental Medicine, Sustaining Health and Performance in the Desert: A Pocket Guide to Environmental Medicine for Operations in Southwest Asia, Technical Note 91-2 (Natick, MA: U.S. Army, Research Institute of Environmental Medicine, 1990).

272. U.S. Army, Walter Reed Army Institute of Research, The General Well-Being of Gulf War Era Service Personnel from the States of Pennsylvania and Hawaii: A Survey (Washington, DC: Walter Reed Army Institute of Research, 1994).

273. U.S. Army, Walter Reed Army Institute of Research, The Threat of Disease and Non-Battle Injury to U.S. Military Personnel on Operation Desert Shield (Washington, DC: U.S. Army, Walter Reed Army Institute of Research, 1990).

274. U.S. Central Intelligence Agency, Office of Weapons, Technology and Proliferation, CIA Report on Intelligence Related to Gulf War Illnesses (McLean, VA: U.S. Central Intelligence Agency, August 1996)..

275. U.S. Congress, Office of Technology Assessment, The Department of Defense Kuwait Oil Fire Health Risk Assessment (The "Persian Gulf Veterans' Registry"), OTA-BP-H-138 (Washington, DC: September 1994).

276. U.S. Congress, Office of Technology Assessment, Technologies Underlying Weapons of Mass Destruction, OTA-BP-ISC-115 (Washington, DC: U.S. Government Printing Office, December 1993).

277. U.S. Department of Defense, Comprehensive Clinical Evaluation Program for Persian Gulf War Veterans: CCEP Report on 18,598 Participants (Washington, DC: U.S. Department of Defense, 1996).

278. U.S. Department of Defense, Comprehensive Clinical Evaluation Program for Persian Gulf War Veterans: CCEP Report on 10,020 Participants (Washington, DC: U.S. Department of Defense, 1995).

279. U.S. Department of Defense, Defense Science Board, Office of the Under Secretary of Defense for Acquisition and Technology, "Report of the Defense Science Board Task Force on Persian Gulf War Health Effects," June 1994.

280. U.S. Department of Defense, "Doc_87_Dust_Control_in Saudi_Arabia_002.txt" downloaded from the Department of Defense Internet GulfLINK site.

281. U.S. Department of Defense, Persian Gulf Veterans' Illnesses Investigation Team, "Coalition Chemical Detections and Health of Coalition Troops in Detection Area," August 1996.

282. U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry, Case Studies in Environmental Medicine: Gasoline Toxicity, September 1993.

283. U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry, Toxicological Profile for Alpha-, Beta-, Gamma-,and Delta-Hexachlorocyclohexane, draft, October 1992.

284. U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry, Toxicological Profile for Fuel Oils (Washington, DC: U.S. Government Printing Office, June 1995).

285. U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry, Toxicological Profile for Gasoline (Washington, DC: U.S. Government Printing Office, June 1995).

286. U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry, Toxicological Profile for Lead, April 1993.

287. U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry, Toxicological Profile for Mustard "Gas" (ATSDR/TP-91/22), September 1992.

288. U.S. Department of Health and Human Service, Agency for Toxic Substances and Disease Registry, Toxicological Profile for Uranium, December 1990.

289. U.S. Department of Health and Human Services, Centers for Disease Control, "Health Advisory for Kuwait and Saudi Arabia," October 1991.

290. U.S. Department of Health and Human Services, Centers for Disease Control, "Postservice Mortality among Vietnam Veterans (The Centers for Disease Control Vietnam Experience Study)," Journal of the American Medical Association 257(6):790-795, 1987.

291. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, "Unexplained Illness among Persian Gulf War Veterans in an Air National Guard Unit: Preliminary Report-August 1990-March 1995," Morbidity and Mortality Weekly Report 44:443-447, 1995.

292. U.S. Department of Labor, Bureau of Labor Statistics, Employment and Earnings 43(1):214, 1996.

293. U.S. Department of Veterans Affairs, Persian Gulf Veterans Coordinating Board, "Unexplained Illnesses among Desert Storm Veterans: A Search for Causes, Treatment, and Cooperation," Archives of Internal Medicine 155:262-268, 1995.

294. U.S. Department of Veterans Affairs, Persian Gulf Veterans Coordinating Board, A Working Plan for Research on Persian Gulf Veterans' Illnesses, August 1995.

295. U.S. Department of Veterans Affairs, Persian Gulf Veterans Coordinating Board, A Working Plan for Research on Persian Gulf Veterans' Illnesses, November 1996.

296. U.S. Department of Veterans Affairs, Persian Gulf Veterans Coordinating Board, Federally-sponsored Research on Persian Gulf Veterans' Illnesses for 1995, Annual Report to Congress, July 1996.

297. U.S. Department of Veterans Affairs, Readjustment Counseling Service, correspondence to Presidential Advisory Committee on Gulf War Veterans' Illnesses, June 1996.

298. U.S. Department of Veterans Affairs, Readjustment Counseling Service, Hispanic Veterans Working Group, Los Hispanos: A Report on Hispanic Veterans, 1995.

299. U.S. Department of Veterans Affairs, Readjustment Counseling Service, Women Veterans Working Group, She Served Too: A Report on Women Veterans, 1995.

300. U.S. Department of Veterans Affairs, Returning Persian Gulf Troops: First Year Findings (West Haven, CT: Department of Veterans Affairs Northeast Program Evaluation Center, 1992).

301. U.S. Environmental Protection Agency, "Other Insecticides, Acaricides, and Repellents," Recognition and Management of Pesticide Poisoning, 4th edition, EPA-540/9-88-001, March 1989.

302. U.S. Environmental Protection Agency, Report to Congress: United States Gulf Environmental Technical Assistance January 27-July 31, 1991, Under Public Law 102-27, Sec. 309, undated.

303. U.S. Food and Drug Administration, Office of the Commission, "Fact Sheet: Potential Mycoplasma Contamination and Anthrax and Botulinum Toxoid Vaccines," correspondence to Presidential Advisory Committee on Gulf War Veterans' Illnesses, September 1996.

304. U.S. Food and Drug Administration, Title 21, Code of Federal Regulations, Part 50.23, "Exception from General Requirements," (55 FR 52813), Dec. 21, 1990.

305. U.S. Food and Drug Administration, Title 21, Code of Federal Regulations, Part 314, Subpart D, Sections 600.80 and 600.90, "Reporting of Adverse Experiences."

306. U.S. General Accounting Office, Operation Desert Storm: Army Not Adequately Prepared to Deal with Depleted Uranium Contamination, GAO/NSIAD-93-90, January 1993.

307. U.S. General Accounting Office, Chemical and Biological Defense: Emphasis Remains Insufficient to Resolve Continuing Problems, GAO/NSID-96-103, March 1996.

308. U.S. General Accounting Office, Chemical Warfare: Soldiers Inadequately Equipped and Trained to Conduct Chemical Operations, GAO/NSIA-01-197, May 1991.

309. U.S. General Accounting Office, Operation Desert Storm: Questions Remain on Possible Exposure to Reproductive Toxicants, GAO/PEMD-94-30, August 1994.

310. U.S. General Accounting Office, Veterans' Compensation: Evidence Considered in Persian Gulf War Undiagnosed Illness Claims, GAO/HEHS-96-112, May 1996.

311. U.S. Interagency Air Assessment Team, Kuwait Oil Fires: Interagency Interim Report, April 1991.

312. U.S. Navy, Naval Medical Research Institute, "Workshop on Medical Effects of Crude Oil Exposures Related to Operation Desert Storm," Dayton, OH, February 1991.

313. U.S. Senate, Committee on Banking, Housing and Urban Affairs, hearing, "United States Chemical and Biological Warfare-Related Dual-Use Exports to Iraq and their Possible Impact on the Health Consequences of the Persian Gulf War," May 25, 1994.

314. U.S. Senate, Committee on Veterans Affairs, staff report, "Is Military Research Hazardous to Veterans' Health? Lessons Spanning Half a Century," (Washington, DC: U.S. Government Printing Office, 1994).

315. Utell, M.J., and Frampton, M.W., "Sulfur Dioxide and Sulfuric Acid Aerosols," Environmental and Occupational Medicine, 2nd edition, W. Rom (ed.) (Boston, MA: Little, Brown and Co., 1992).

316. Vasterling, J.J., Psychology Service, New Orleans Veterans Affairs Medical Center, "Evaluation of Memory Complaints," presentation at Department of Veterans Affairs National Conference: Current Concepts of Persian Gulf Veterans Illnesses, Long Beach, CA, August 1996.

317. Vasterling, J.J., Psychology Service, New Orleans Veterans Affairs Medical Center, presentation to Presidential Advisory Committee on Gulf War Veterans' Illnesses staff, April 1996.

318. Vasterling, J.J., Brailey, K., Constans, J.I., et al., "Assessment of Intellectual Resources in Gulf War Veteran: Relationship to PTSD," Assessment, in press.

319. Vasterling, J.J., Root, L., Brailey, K., et al., " Attention and Memory Performances in Post-traumatic Stress Disorder," presentation at 22nd Annual Meeting of the International Neuropsychological Society, February 1994.

320. Verschoyle, R.D., Brown, A.W., Nolan, C., et al., "A Comparison of the Acute Toxicity, Neuropathology, and Electrophysiology of N,N-diethyl-m-toluamide and N,N-dimethyl-2,2-diphenylacetamide in Rats," Fundamentals of Applied Toxicology 18:79-88, 1992.

321. Voelz, G., Guest Scientist, Epidemiology Division, Los Alamos National Laboratory, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, August 1996.

322. Voelz, G., "Uranium," Hazardous Materials Toxicology, J. Sullivan and G. Krieger (eds.) (Baltimore, MD: Williams and Wilkins, 1992).

323. Wages, R., former NBC Fox Reconnaissance Vehicle Commander, public comment before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, April 1996.

324. Wallner, P.F., Staff Director, Senior Level Oversight Board, Office of the Assistant Secretary of Defense (Health Affairs), memorandum, "Identification and Processing of Sensitive Operational Records," Nov. 3, 1995.

325. Wallner, P.F., Staff Director, Senior Level Oversight Board, Office of the Assistant Secretary of Defense (Health Affairs), testimony and remarks before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, October 1995, April, May, July, and August 1996.

326. Watanabe, K.K., and Kang, H.K., "Military Service in Vietnam and the Risk of Death from Trauma and Selected Cancers," Annals of Epidemiology 5:407-412, 1995.

327. Weddle, J.R., Chan, T.C., and Thompson, K., "Effectiveness of a Dot-Blot Immunoassay of Anti-Rickettsia Tsutsugamushi Antibodies for Serologic Analysis of Scrub Typhus," American Journal of Tropical Medicine and Hygiene 53(1):43-46, 1995.

328. Weiss, L.M., ". . . And Now Microsporidiosis," Annals of Internal Medicine 123(12):954-956, 1995.

329. West, L., Mercer, S., and Altheimer, E., "Operation Desert Storm: The Response of a Social Work Outreach Team," Social Work in Health Care 19(2):81-98, 1993.

330. White, J.P., Deputy Secretary, Department of Defense, correspondence to the Presidential Advisory Committee on Gulf War Veterans' Illnesses, December 1996.

331. White, J.P., Deputy Secretary, Department of Defense, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, November 1996.

332. White, R.F., Diamond R., Krengel M., et al., "Validation of the NES 2 in Patients with Neurologic Disorders," Neurotoxicology and Teratology 18:441-448, 1996.

333. Wolfe, F., Smythe, H., Yunus, M., et al., "The American College of Rheumatology 1990 Criteria for Fibromyalgia, Arthritis and Rheumatism," Arthritis and Rheumatism 33:160-172, 1990.

334. Wolfe, J., Associate Professor, Tufts University School of Medicine, presentation to Presidential Advisory Committee on Gulf War Veterans' Illnesses staff, April 1996.

335. Wolfe, J., Brown, P., and Bucsela, M.L., "Symptom Responses of Female Vietnam Veterans to Operation Desert Storm," American Journal of Psychiatry 149:676-679, 1992.

336. Wolfe, J., Brown, P.J., and Kelley, J.M., "Reassessing War Stress: Exposure and the Persian Gulf War," Journal of Social Issues 49(4):15-31, 1993.

337. Wolfe, J., Keane, T.M., and Young, B.L., "From Soldier to Civilian: Acute Adjustment Patterns of Returned Persian Gulf Veterans," Emotional Aftermath of the Persian Gulf War, R.J. Ursano and A.E. Norwood (eds.) (Washington, DC: American Psychiatric Press, Inc., 1996).

338. Wolfe, J., Kelley, J.M., Bucsela M.L., et al., "Fort Devens Reunion Survey: Report of Phase I," Returning Persian Gulf Troops: First Year Findings (West Haven, CT: Department of Veterans Affairs Northeast Program Evaluation Center, 1992).

339. World Meteorological Organization, report of the Second WMO Meeting of Experts to Assess the Response to and Atmospheric Effects of the Kuwait Oil Fires, WMO/TD-No. 512, Geneva, Switzerland, May 1992.

340. Wright, K.M., Marlowe, D.H., and Gifford, R.K., "Deployment Stress and Operation Desert Shield: Preparation for the War," Emotional Aftermath of the Persian Gulf War, R.J. Ursano and A.E. Norwood (eds.) (Washington, DC: American Psychiatric Press, Inc., 1996).

341. Wrenn, M.E., Durbin, P.W., Howard, B., et al., "Metabolism of Ingested U and Ra," Health Physics 48(5):601-633, 1985.

342. Writer, J.V., Epidemiologist, Division of Preventive Medicine, Walter Reed Army Institute of Research, personal communications to Presidential Advisory Committee on Gulf War Veterans' Illnesses, June, August, September 1996.

343. Writer, J.V., Defraites, R.F., and Brundage, J.F., "Comparative Mortality among U.S. Military Personnel in the Persian Gulf Region and Worldwide During Operations Desert Shield and Desert Storm," Journal of the American Medical Association 275(2):118-121, 1996.

Final Report w

w Presidential Advisory Committee